Literature DB >> 23105586

Effect of increasing duration of diabetes mellitus type 2 on glycated hemoglobin and insulin sensitivity.

Meena Verma1, Sangeeta Paneri, Preetha Badi, P G Raman.   

Abstract

Non-insulin dependent diabetes mellitus (NIDDM) is the most rapidly growing chronic metabolic disorder in the world. With advancement in the age and duration of diabetes there is a gradual tendency for the level of blood sugar to rise along with a subsequent increase in the HbA1c as well as in the fasting insulin level. Whether this is an aging process or increased frequency of diabetes is still controversial. The correlation between glucose and insulin sensitivity is consistent with the idea that the degree of chronic hyperglycemia is a cause of excessive insulin resistance in type 2 diabetes, i.e. the insulin resistance which characterizes type 2 diabetes but not nondiabetic subjects matched for age, gender, family history and duration of diabetes. The study comprised a total of 76 subjects out of which 30 were normal, non-diabetic persons and the rest 46 were diabetics with different duration of time in years, after being diagnosed diabetic. Data was analyzed after dividing the subjects into four groups-Group 1 comprised of one year old diabetics, Group 2 was made up of those, who had diabetes, for the past 2-5 years, Group 3 included patients who were diabetic since more than 5 years and Group 4 included non-diabetics as the normal control group. The results obtained indicated that the HbA1c levels showed a significant increase with the duration of diabetes as well as the insulin level showed a significant correlation after adjustment for age, sex and duration of diabetes.

Entities:  

Keywords:  Fasting Blood Glucose; Glycation; HbA1c; Insulin Resistance; Post Prandial Blood Glucose

Year:  2006        PMID: 23105586      PMCID: PMC3453763          DOI: 10.1007/BF02913083

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  27 in total

1.  Further identification of the nature and linkage of the carbohydrate in hemoglobin A1c.

Authors:  H F Bunn; D N Haney; K H Gabbay; P M Gallop
Journal:  Biochem Biophys Res Commun       Date:  1975-11-03       Impact factor: 3.575

Review 2.  Clinical practice. Initial management of glycemia in type 2 diabetes mellitus.

Authors:  David M Nathan
Journal:  N Engl J Med       Date:  2002-10-24       Impact factor: 91.245

Review 3.  Glucose toxicity.

Authors:  L Rossetti; A Giaccari; R A DeFronzo
Journal:  Diabetes Care       Date:  1990-06       Impact factor: 19.112

4.  Glycosylation of proteins. Lack of influence of aging.

Authors:  U M Kabadi
Journal:  Diabetes Care       Date:  1988-05       Impact factor: 19.112

5.  The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type II diabetes: the Insulin Resistance Atherosclerosis Study.

Authors:  L Mykkänen; D J Zaccaro; C N Hales; A Festa; S M Haffner
Journal:  Diabetologia       Date:  1999-09       Impact factor: 10.122

Review 6.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes.

Authors:  Joseph L Evans; Ira D Goldfine; Betty A Maddux; Gerold M Grodsky
Journal:  Endocr Rev       Date:  2002-10       Impact factor: 19.871

7.  Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes.

Authors:  Michael J Sampson; Nitin Gopaul; Isabel R Davies; David A Hughes; Martin J Carrier
Journal:  Diabetes Care       Date:  2002-03       Impact factor: 19.112

8.  Infusion of insulin impairs human adipocyte glucose metabolism in vitro without decreasing adipocyte insulin receptor binding.

Authors:  L Mandarino; B Baker; R Rizza; J Genest; J Gerich
Journal:  Diabetologia       Date:  1984-09       Impact factor: 10.122

9.  Glycosylated haemoglobin and blood glucose levels in Libyan diabetic patients.

Authors:  G M Rao; L O Morghom; A A Abukhris; S S Mansori; F A Alphgih; L Y Ragale
Journal:  Trop Geogr Med       Date:  1986-12

10.  The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.

Authors: 
Journal:  Diabetes       Date:  1995-08       Impact factor: 9.461

View more
  16 in total

1.  Inadequate control of diabetes and metabolic indices among diabetic patients: A population based study from the Kerman Coronary Artery Disease Risk Study (KERCADRS).

Authors:  Gholamreza Yousefzadeh; Mostafa Shokoohi; Hamid Najafipour
Journal:  Int J Health Policy Manag       Date:  2014-12-23

2.  Self Care Activities, Diabetic Distress and other Factors which Affected the Glycaemic Control in a Tertiary Care Teaching Hospital in South India.

Authors:  Sekhar Tvd Sasi; Madhavi Kodali; Kalyan Chakravarthy Burra; Baby Shalini Muppala; Parvathi Gutta; Murali Krishna Bethanbhatla
Journal:  J Clin Diagn Res       Date:  2013-03-22

3.  Use of glycated hemoglobin (HbA(1C)) and impaired glucose tolerance in the screening of undiagnosed diabetes in the Malaysian population.

Authors:  Rajes Qvist; Ikram Shah Ismail; Karuthan Chinna; Sekaran Muniandy
Journal:  Indian J Clin Biochem       Date:  2008-10-01

4.  The role of TNF-α G-308A promoter polymorphism in glycemic control in Type 2 diabetes patients.

Authors:  S I Al-Azzam; O F Khabour; K H Alzoubi; M W Ghanma; A Y Alhasan
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

5.  Early Menopause in Type 2 Diabetes - A Study from a South Indian Tertiary Care Centre.

Authors:  T V D Sasi Sekhar; Soumya Medarametla; Arifa Rahman; Satya Sahi Adapa
Journal:  J Clin Diagn Res       Date:  2015-10-01

6.  Pharmacometric Approaches to Guide Dose Selection of the Novel GPR40 Agonist TAK-875 in Subjects With Type 2 Diabetes Mellitus.

Authors:  H Naik; J Lu; C Cao; M Pfister; M Vakilynejad; E Leifke
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-01-09

7.  HbA1c measured in stored erythrocytes is positively linearly associated with mortality in individuals with diabetes mellitus.

Authors:  Diewertje Sluik; Heiner Boeing; Jukka Montonen; Rudolf Kaaks; Annekatrin Lukanova; Annelli Sandbaek; Kim Overvad; Larraitz Arriola; Eva Ardanaz; Calogero Saieva; Sara Grioni; Rosario Tumino; Carlotta Sacerdote; Amalia Mattiello; Annemieke M W Spijkerman; Daphne L van der A; Joline W J Beulens; Susan van Dieren; Peter M Nilsson; Leif C Groop; Paul W Franks; Olov Rolandsson; Bas Bueno-de-Mesquita; Ute Nöthlings
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240

8.  Evaluation of serum zinc status and glycated hemoglobin of type 2 diabetes mellitus patients in a tertiary care hospital of assam.

Authors:  Gautom Kumar Saharia; Rohini Kanta Goswami
Journal:  J Lab Physicians       Date:  2013-01

9.  Prevalence and determinants of poor glycaemic control: a cross-sectional study among Moroccan type 2 diabetes patients.

Authors:  Ahmed Chetoui; Kamal Kaoutar; Soufiane Elmoussaoui; Kaltoum Boutahar; Abdesslam El Kardoudi; Fatiha Chigr; Mohamed Najimi
Journal:  Int Health       Date:  2020-01-20       Impact factor: 3.131

10.  Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials.

Authors:  Kathrin Herrmann; Steven C Brunell; Yan Li; Ming Zhou; David G Maggs
Journal:  Adv Ther       Date:  2016-04-12       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.